Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Caixiu Lin, Yueli Zhu, Ziqi Fan, Baorong Zhang, Yanxing Chen
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The global prevalence of dementia: a systematic review and metaanalysis
10.1016/j.jalz.2012.11.007 · 2013
Evidence for ordering of Alzheimer disease biomarkers
10.1001/archneurol.2011.183 · 2011
10.1212/wnl.0000000000002923
10.1212/wnl.0000000000002923
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial
10.1212/01.wnl.0000159740.16984.3c · 2005
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
10.1212/wnl.0b013e3181c67808 · 2009
10.1056/nejmoa1312889
10.1056/nejmoa1312889
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
10.1186/s13195-017-0318-y · 2017
10.1016/j.trci.2017.05.003
10.1016/j.trci.2017.05.003
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
10.1186/s13195-018-0424-5 · 2018
10.1056/nejmoa1210951
datacite
Confidence 0%
10.1056/nejmoa1210951
Tau immunotherapies for Alzheimer’s disease
10.1080/13543784.2019.1619694 · 2019
10.1016/s0140-6736(10)61349-9
10.1016/s0140-6736(10)61349-9
10.1016/j.npep.2015.06.008
10.1016/j.npep.2015.06.008
10.1096/fj.201601309
10.1096/fj.201601309
10.1016/j.bbadis.2013.09.010
10.1016/j.bbadis.2013.09.010
Calcium Hypothesis of Alzheimer's disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis
10.1016/j.jalz.2016.12.006 · 2017
Neuroinflammation and Alzheimer's disease: implications for microglial activation
10.2174/1567205014666170203141717 · 2017
10.1016/s1474-4422(15)70016-5
10.1016/s1474-4422(15)70016-5
Systemic inflammation and disease progression in Alzheimer disease
10.1212/wnl.0b013e3181d5df7f · 2010
Protective effects of NSAIDs on the development of Alzheimer disease
10.1212/01.wnl.0000311269.57716.63 · 2008
Risk of Alzheimer's disease and duration of NSAID use
10.1212/wnl.48.3.626 · 1997
Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's disease anti-inflammatory prevention trial
10.1002/gps.2723 · 2012
Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis
10.3233/jad-2010-100018 · 2010
Systemic inflammation and disease progression in Alzheimer disease
10.1212/wnl.0b013e3181b6bb95 · 2009
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
10.1186/1742-2094-9-151 · 2012
Enhanced susceptibility of triple transgenic Alzheimer's disease (3xTg-AD) mice to acute infection
10.1186/s12974-017-0826-5 · 2017
10.1038/nrmicro2876
10.1038/nrmicro2876
Extensive unexplored human microbiome diversity revealed by Over 150,000 genomes from metagenomes spanning age, geography, and lifestyle
10.1016/j.cell.2019.01.001 · 2019
10.1111/imr.12567
10.1111/imr.12567
Intestinal barrier and gut microbiota: shaping our immune responses throughout life
10.1080/21688370.2017.1373208 · 2017
10.1111/apt.14384
10.1111/apt.14384
Role of microbiota and innate immunity in recurrent Clostridium difficile infection
10.1155/2014/462740 · 2014
10.1016/j.cell.2004.07.002
10.1016/j.cell.2004.07.002
10.1016/j.cub.2011.05.039
10.1016/j.cub.2011.05.039
10.1038/nri1391
10.1038/nri1391
10.1016/j.smim.2006.12.004
10.1016/j.smim.2006.12.004
10.1084/jem.20031023
10.1084/jem.20031023
10.7554/elife.04066
10.7554/elife.04066
10.1074/jbc.m113.523480
10.1074/jbc.m113.523480
10.1038/ni1411
10.1038/ni1411
The claudin-like protein HPO-30 is required to maintain LAChRs at the C. elegans neuromuscular junction
10.1523/jneurosci.3487-17.2018 · doi-reference
10.1073/pnas.1215165110
10.1073/pnas.1215165110 · doi-reference
Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial
10.3389/fnagi.2016.00256 · doi-reference
Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease
10.1038/s41598-017-13368-2 · doi-reference
Lactobacilli-fermented cow's milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo
10.1017/s0022029917000620 · doi-reference
Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies
10.1016/j.pep.2017.11.007 · doi-reference
10.4049/jimmunol.1303369
10.4049/jimmunol.1303369 · doi-reference
10.1016/j.carbpol.2015.04.026
10.1016/j.carbpol.2015.04.026 · doi-reference
10.1016/j.molimm.2014.11.014
10.1016/j.molimm.2014.11.014 · doi-reference
10.1371/journal.ppat.1002076
10.1371/journal.ppat.1002076 · doi-reference
Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages
10.4049/jimmunol.0901569 · doi-reference
10.1016/j.phrs.2017.12.009
10.1016/j.phrs.2017.12.009 · doi-reference
10.1038/mi.2016.18
10.1038/mi.2016.18 · doi-reference
10.1128/iai.68.12.7010-7017.2000
10.1128/iai.68.12.7010-7017.2000 · doi-reference
10.1053/gast.2002.33662
10.1053/gast.2002.33662 · doi-reference
10.1016/j.jalz.2018.06.3040
10.1016/j.jalz.2018.06.3040 · doi-reference
Alzheimer's disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection
10.1016/j.neuron.2018.06.030 · doi-reference
Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
10.3233/jad-131394 · doi-reference
10.1096/fj.03-0364fje
10.1096/fj.03-0364fje · doi-reference
Prolonged elevation in hippocampal Abeta and cognitive deficits following repeated endotoxin exposure in the mouse
10.1016/j.bbr.2012.01.010 · doi-reference
LPS-induced neuroinflammatory effects do not recover with time
10.1097/00001756-200006050-00032 · doi-reference
Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus
10.3389/fcimb.2017.00318 · doi-reference
10.1212/wnl.0000000000003391
10.1212/wnl.0000000000003391 · doi-reference
10.1128/iai.00911-12
10.1128/iai.00911-12 · doi-reference
10.1007/s13238-016-0338-6
10.1007/s13238-016-0338-6 · doi-reference
Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines
10.1073/pnas.052709699 · doi-reference
10.1111/j.1462-2920.2007.01418.x
10.1111/j.1462-2920.2007.01418.x · doi-reference
10.1016/j.mib.2012.12.001
10.1016/j.mib.2012.12.001 · doi-reference
10.1128/aem.02107-08
10.1128/aem.02107-08 · doi-reference
10.1126/science.1067484
10.1126/science.1067484 · doi-reference
Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP(SWE)/PS1(ΔE9) murine model of Alzheimer's disease
10.1038/s41598-017-11047-w · doi-reference
Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease
10.1038/srep30028 · doi-reference
10.1016/j.neurobiolaging.2016.08.019
10.1016/j.neurobiolaging.2016.08.019 · doi-reference
10.3233/jad-180176
10.3233/jad-180176 · doi-reference
Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
10.1111/lam.12882 · doi-reference
10.1038/srep41802
10.1038/srep41802 · doi-reference
Impaired IL-17 production in gut-residing immune cells of 5xFAD mice with Alzheimer's disease pathology
10.3233/jad-170538 · doi-reference
Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system
10.3233/jad-142259 · doi-reference
10.1002/ana.410300509
10.1002/ana.410300509 · doi-reference
10.3233/jad-150859
10.3233/jad-150859 · doi-reference